Brighthouse Financial, Inc.
BHFBrighthouse Financial, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is already 1 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (1 weeks in) while the P/BV sits at the 64th percentile of its own 5-year range. Underneath, the last four quarters read deteriorating, with the the net margin at −49.7%. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Brighthouse Financial, Inc. trades at $62.7, in a confirmed uptrend and 1 weeks into that stage. That is +1.0% against its own 200-day average. It sits at 85% of a 52-week range of $43 to $66. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a confirmed uptrend — week 1 of stage 2. At $62.7 it trades +1.0% versus its 200-day average and sits at 85% of its 52-week range ($43–$66).
Against the market, two honest reads. Cumulative: over the last 9.0 years the stock moved +8% while the S&P 500 moved +216% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-07-17) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Brighthouse Financial, Inc. trades at 0.7× P/BV, mid-range by its own standards (64th percentile). Its long-run median P/BV is 0.6×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 0.7× is mid-range by its own standards (64th percentile), against a long-run median of 0.6× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about −1% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved +35.8% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +5.9%/yr price move, ~−12.3%/yr came from book-value growth and ~+18.2 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Brighthouse Financial, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +43.4% | −0.5% | — | — |
| Profit | +12.8% | −51.6% | — | — |
| EPS | +23.1% | −51.9% | — | — |
| Stock price | +35.8% | +5.5% | +5.9% | — |
4-Factor Sector Score
26.7/100 — rank 15 of 17 in Insurance - Life · 55% evidence confidence
Brighthouse Financial, Inc. scores 26.7 out of 100 against the 17 companies it is compared with in Insurance - Life, ranking 15. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 10.7 + 4.2 + 9.8 + 2 = 26.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Brighthouse Financial, Inc. reported $1.5 B of income in the Mar 26 quarter, −36.0% year on year. Over 4 years it has compounded at 8.0% a year. The last full year, FY25, came in at $6.8 B. The last four reported quarters add to $5.9 B.
FY25 revenue came in at $6.8 B (+43.4% on the year), capping 4 years at 8.0% compound. The latest quarter (Mar 26) printed $1.5 B, −36.0% year on year.
Pace check: the last four quarters averaged −11.3% growth against the decade's 8.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −16.2% over the last 4 quarters against +42.8%/yr over the last 8 — rolling over.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Brighthouse Financial, Inc.'s net margin is −49.7% in the Mar 26 quarter, −38.4 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −26.9% to 56.5%. The current quarter is running below every full year in that window.
The latest quarter's net margin is −49.7%, −38.4 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −26.9%–56.5%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Brighthouse Financial, Inc. posted a net loss of $0.8 B in the Mar 26 quarter. Full-year FY25 profit was $0.4 B. The 4-year compound rate is −28.1%. That loss is 49.7% of the quarter's revenue. The same quarter a year earlier lost $0.3 B. 5 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.8 B, null year on year. On the full year, FY25 printed $0.4 B (+12.8%), and the 4-year compound rate is −28.1%.
Pace comparison, last four quarters: profit +95.9% vs revenue −11.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Brighthouse Financial, Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Brighthouse Financial, Inc.'s revenue grew +43.4% in FY25 to $6.8 B, so the book is growing. The latest quarter ran −36.0% year on year. The net margin on that income is −49.7%, −38.4 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $6.8 B, +43.4% on the year, and the latest quarter ran −36.0% year on year. The net margin on that revenue is −49.7% this quarter (−38.4 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Brighthouse Financial, Inc. earns a return on equity of 6% in FY25. Its trough over the ladder below was −22% in FY23. On the asset side every $100 of the balance sheet earned about $0.05, which is the return before leverage is applied.
FY25 ROE came in at 6%, recovered from a FY23 trough of −22%. On assets, the latest reading is about 0.05% — every $100 the bank deploys earns roughly $0.05 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded −28.1% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend
Brighthouse Financial, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Brighthouse Financial, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
9.5% of Brighthouse Financial, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 10.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 9.5% of the float is sold short, and at typical trading volumes it would take about 10.6 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Brighthouse Financial, Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Globe Life Inc.GL | 69.0/100Favorable setup60% evidence | BREAKING OUT | 21.9/35 Income — · PAT — 26% evidence | 18.6/25 ROA 2.1% · ROE 10.6% · GNPA — 68% evidence | 11.4/20 P/BV 1.78× · P/BV÷ROE 0.17 70% evidence | 17.1/20 RS sector 7.1% · RS bench 11.9% · 1Y 30.8%9 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 18.6 + 11.4 + 17.1 = 69 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Lincoln National CorporationLNC | 63.3/100Mixed-positive evidence60% evidence | BREAKING OUT | 19.4/35 Income — · PAT — 26% evidence | 11.6/25 ROA 0.3% · ROE 12.7% · GNPA — 68% evidence | 16.7/20 P/BV 0.6× · P/BV÷ROE 0.05 70% evidence | 15.6/20 RS sector 1.9% · RS bench 6.5% · 1Y 23.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.6 + 16.7 + 15.6 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3CNO Financial Group, Inc.CNO | 60.1/100Mixed-positive evidence60% evidence | BREAKING OUT | 19.2/35 Income — · PAT — 26% evidence | 16.5/25 ROA 1.9% · ROE 4.9% · GNPA — 68% evidence | 6.5/20 P/BV 1.84× · P/BV÷ROE 0.38 70% evidence | 17.9/20 RS sector 9.3% · RS bench 14.2% · 1Y 51.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 16.5 + 6.5 + 17.9 = 60.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 4Primerica, Inc.PRI | 57.4/100Mixed-positive evidence76% evidence | BREAKING OUT | 22.3/35 Income 6.4% · PAT 54.1% 71% evidence | 15.5/25 ROA 1.3% · ROE 8% · GNPA — 68% evidence | 5.7/20 P/BV 3.12× · P/BV÷ROE 0.39 70% evidence | 13.9/20 RS sector 1.1% · RS bench 5.7% · 1Y 23.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 15.5 + 5.7 + 13.9 = 57.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Abacus Global Management, Inc.ABX | 50.5/100Mixed-positive evidence61% evidence | BREAKING OUT | 17.4/35 Income 86.6% · PAT — 45% evidence | 12.3/25 ROA 1.4% · ROE 1.7% · GNPA — 68% evidence | 3.8/20 P/BV 1.79× · P/BV÷ROE 1.05 70% evidence | 17.0/20 RS sector 14.9% · RS bench 19.9% · 1Y 82.8%6 of 12 weeks ahead 70% evidence |
| Exact sum: 17.4 + 12.3 + 3.8 + 17 = 50.5 · Decision use: Price leads the evidence: RS versus the benchmark is 19.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6Manulife Financial CorporationMFC | 47.6/100Mixed-negative evidence76% evidence | BREAKING OUT | 20.1/35 Income 21% · PAT 20.7% 71% evidence | 9.7/25 ROA 0.4% · ROE 2.3% · GNPA — 68% evidence | 4.5/20 P/BV 1.58× · P/BV÷ROE 0.69 70% evidence | 13.3/20 RS sector 6.4% · RS bench 11.2% · 1Y 48.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 9.7 + 4.5 + 13.3 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Aflac IncorporatedAFL | 46.2/100Mixed-negative evidence76% evidence | TURNING | 23.4/35 Income 7.3% · PAT 29% 71% evidence | 12.4/25 ROA 0.9% · ROE 3.6% · GNPA — 68% evidence | 5.0/20 P/BV 1.87× · P/BV÷ROE 0.52 70% evidence | 5.4/20 RS sector -4.8% · RS bench -0.4% · 1Y 20.9%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 12.4 + 5 + 5.4 = 46.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -4.8% and the one-year return is 20.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8F&G Annuities & Life, Inc.FG | 45.2/100Mixed-negative evidence67% evidence | FADING | 23.5/35 Income 18.2% · PAT 7.1% 45% evidence | 9.7/25 ROA 0.3% · ROE 5.4% · GNPA — 68% evidence | 8.6/20 P/BV 0.73× · P/BV÷ROE 0.14 70% evidence | 3.4/20 RS sector -13.1% · RS bench -9.1% · 1Y -12.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.5 + 9.7 + 8.6 + 3.4 = 45.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.1% and the one-year return is -12.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9MetLife, Inc.MET | 44.8/100Mixed-negative evidence76% evidence | BREAKING OUT | 12.8/35 Income 5.6% · PAT -20% 71% evidence | 9.9/25 ROA 0.2% · ROE 4.2% · GNPA — 68% evidence | 6.2/20 P/BV 1.67× · P/BV÷ROE 0.4 70% evidence | 15.9/20 RS sector 3% · RS bench 7.7% · 1Y 26%10 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 9.9 + 6.2 + 15.9 = 44.8 · Decision use: Price leads the evidence: RS versus the benchmark is 7.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Prudential Financial, Inc.PRU | 42.9/100Mixed-negative evidence76% evidence | BREAKING OUT | 18.4/35 Income 4.1% · PAT 51% 71% evidence | 6.9/25 ROA 0.1% · ROE 1.8% · GNPA — 68% evidence | 4.8/20 P/BV 1.06× · P/BV÷ROE 0.59 70% evidence | 12.8/20 RS sector -0.2% · RS bench 4.4% · 1Y 19.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 6.9 + 4.8 + 12.8 = 42.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Jackson Financial Inc.JXN | 42.5/100Thin evidence · provisional55% evidence | BREAKING OUT | 11.1/35 Income -20.5% · PAT -311.5% 45% evidence | 4.7/25 ROA -0.1% · ROE -4.1% · GNPA — 68% evidence | 9.8/20 P/BV 0.78× · P/BV÷ROE — 10% evidence | 16.9/20 RS sector 7.5% · RS bench 12.4% · 1Y 47.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11.1 + 4.7 + 9.8 + 16.9 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Security National Financial CorporationSNFCA | 41.9/100Mixed-negative evidence70% evidence | BASING | 17.0/35 Income 1.8% · PAT 40% 71% evidence | 9.7/25 ROA 0.5% · ROE 1.8% · GNPA — 68% evidence | 7.6/20 P/BV 0.58× · P/BV÷ROE 0.32 70% evidence | 7.6/20 RS sector -4.1% · RS bench 0.3% · 1Y 15.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17 + 9.7 + 7.6 + 7.6 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Unum GroupUNM | 41.7/100Mixed-negative evidence60% evidence | LEADER | 14.2/35 Income — · PAT — 26% evidence | 10.9/25 ROA 0.5% · ROE 2.3% · GNPA — 68% evidence | 5.2/20 P/BV 1.31× · P/BV÷ROE 0.57 70% evidence | 11.4/20 RS sector 0% · RS bench 4.6% · 1Y 31.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 10.9 + 5.2 + 11.4 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Genworth Financial, Inc.GNW | 27.7/100Adverse evidence76% evidence | TURNING | 10.4/35 Income 1% · PAT 0.3% 71% evidence | 6.8/25 ROA 0.1% · ROE 0.8% · GNPA — 68% evidence | 5.9/20 P/BV 0.35× · P/BV÷ROE 0.44 70% evidence | 4.6/20 RS sector -4.4% · RS bench -0.1% · 1Y 18.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 10.4 + 6.8 + 5.9 + 4.6 = 27.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Brighthouse Financial, Inc.this pageBHF | 26.7/100Thin evidence · provisional55% evidence | ASLEEP | 10.7/35 Income -16.1% · PAT -109.7% 45% evidence | 4.2/25 ROA -0.3% · ROE -14% · GNPA — 68% evidence | 9.8/20 P/BV 0.62× · P/BV÷ROE — 10% evidence | 2.0/20 RS sector -10.2% · RS bench -6.1% · 1Y 40.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.7 + 4.2 + 9.8 + 2 = 26.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Prudential plcPUK | 50.7/100Thin evidence · provisional50% evidence | BASING | 18.7/35 Income — · PAT — 8% evidence | 17.8/25 ROA 2.9% · ROE 15.4% · GNPA — 51% evidence | 13.1/20 P/BV 1.96× · P/BV÷ROE 0.13 70% evidence | 1.1/20 RS sector -11.2% · RS bench -7.1% · 1Y 16%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 17.8 + 13.1 + 1.1 = 50.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Citizens, Inc.CIA | 35.4/100Thin evidence · provisional47% evidence | ASLEEP | 18.4/35 Income 7% · PAT 88.9% 29% evidence | 10.2/25 ROA — · ROE 1% · GNPA — 34% evidence | 3.8/20 P/BV 1.06× · P/BV÷ROE 1.06 70% evidence | 3.0/20 RS sector -26.3% · RS bench -22.8% · 1Y 1.3%3 of 12 weeks ahead 70% evidence |
| Exact sum: 18.4 + 10.2 + 3.8 + 3 = 35.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Brighthouse Financial, Inc.'s stock price today?
Brighthouse Financial, Inc. trades at $62.7, +35.8% over the past year. The company is valued at $4.0 B. The stock sits at 85% of its 52-week range of $43–$66, +1.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 1 weeks in. — as of 5 August 2026.
What were Brighthouse Financial, Inc.'s latest quarterly results?
Brighthouse Financial, Inc. reported total income of $1.5 B and a net loss of $0.8 B for the Mar 26 quarter. Earnings per share were $−13.82. The net margin was −49.7%, 38.4 pp lower than a year earlier. — as of 5 August 2026.
What is Brighthouse Financial, Inc.'s revenue?
Brighthouse Financial, Inc. reported revenue of $1.5 B in the Mar 26 quarter, −36.0% year on year. For the full FY25 fiscal year, revenue was $6.8 B (+43.4%). Over the last 4 years revenue compounded at 8.0% a year. — as of 5 August 2026.
What is Brighthouse Financial, Inc.'s profit?
Brighthouse Financial, Inc. earned $−0.8 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.4 B. The net margin ran −49.7% in the latest quarter. — as of 5 August 2026.
What is Brighthouse Financial, Inc.'s market cap?
Brighthouse Financial, Inc.'s market capitalisation is $4.0 B at a stock price of $62.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Brighthouse Financial, Inc.'s P/BV ratio?
Brighthouse Financial, Inc. trades at a P/BV of 0.7×, at the 64th percentile of its own 5-year range, against a long-run median of 0.6×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Brighthouse Financial, Inc. pay a dividend?
No — Brighthouse Financial, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Brighthouse Financial, Inc. overvalued?
On its own history, Brighthouse Financial, Inc. looks mid-range against its own history: its P/BV of 0.7× sits at the 64th percentile of its 5-year range (long-run median 0.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
How is Brighthouse Financial, Inc. performing?
Brighthouse Financial, Inc. is in a confirmed uptrend, 1 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is Brighthouse Financial, Inc. in an uptrend?
Yes — the price is in a confirmed uptrend (week 1 of stage 2), trading +1.0% versus its 200-day average and at 85% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Brighthouse Financial, Inc. beating the market?
Not lately — on a trailing-13-week view Brighthouse Financial, Inc. is currently behind the S&P 500 (3 weeks and counting; last ahead the week of 2026-07-17), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 9.0 years the stock moved +8% against the S&P 500's +216% — behind the index over the full window. — as of 5 August 2026.
Will Brighthouse Financial, Inc.'s stock price go up?
This page publishes no price forecast for Brighthouse Financial, Inc. What it measures instead: the stock price is $62.7, the price is in a confirmed uptrend 1 weeks in. Its P/BV of 0.7× sits at the 64th percentile of its own 5-year range. — as of 5 August 2026.
Is the market betting against Brighthouse Financial, Inc.?
Somewhat — short interest is 9.5% of Brighthouse Financial, Inc.'s tradable float, about 10.6 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Is Brighthouse Financial, Inc.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Brighthouse Financial, Inc., so this page says that plainly. The cleanest available reads are revenue growth (+43.4% in FY25) and the net margin on it (−49.7%) — as of 5 August 2026.
Where is Brighthouse Financial, Inc. in its business cycle?
Brighthouse Financial, Inc.'s FY25 net margin was 6.5%, against a 5-year band of −26.9%–56.5%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −49.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Brighthouse Financial, Inc. story?
Biggest watch item: the price is already 1 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Brighthouse Financial, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Brighthouse Financial, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.